August 21, 2014 7:42 AM ET

Life Sciences Tools and Services

Company Overview of ChemDiv, Inc.

Company Overview

ChemDiv, Inc., a discovery and development contract research organization, provides discovery outsource solutions for pharmaceutical and biotechnology companies in the United States and internationally. Its projects include the discovery and optimization of small molecules for a range of therapeutic targets and pathways in oncology, inflammation, and CNS; the VIP discovery chemistry technology access programs; and focused diversity libraries for biological screening, HTS collaborations, and integrated discovery and development projects. The company also develops and executes pipeline/portfolio programs encompassing multiple targets and therapeutic indications, as well as provides preclinical...

6605 Nancy Ridge Drive

San Diego, CA 92121

United States

Founded in 1990





Key Executives for ChemDiv, Inc.

Chief Executive Officer
Chief Technology Officer and Vice President of Biology
Senior Vice President of Corporate Development and General Manager
Compensation as of Fiscal Year 2014.

ChemDiv, Inc. Key Developments

ChemDiv Launches MacroLead (TM) Platform

ChemDiv, Inc. announced that its team assembled a focused library of Bromodomains (BRDs) inhibitors/modulators. This library represents a selection of drug-like compounds aimed at modulating protein-protein interaction of BRD containing proteins with different partners involved in significant physiological process. Library of 7,500-compound has been assembled using i) in house structural biology insight, ii) molecular stimulation-modeling; iii) virtual screening of ChemDiv's novel chemistries and iv) medicinal chemistry filtering/ranking of the resulting hits.

COARE Biotechnology and ChemDiv, Inc. Announce Co-Marketing and Service Collaboration

COARE Biotechnology and ChemDiv, Inc. announced the formation of a strategic alliance that will offer a fully integrated gene-to-clinic services aimed at development of therapeutic agents that selectively affect cancer stem cells. Under terms of this agreement, COARE contributes its pioneering research on the role of Doublecortin-like Kinase 1 (DCLK1) in proliferation and differentiation of CSC including relevant screening reagents and know-how. ChemDiv provides chemistry and biology expertise, including small molecule screening libraries, Medicinal Chemistry support, assay adaptation, development and implementation, in vivo testing and advanced preclinical services including DMPK/tox.

Similar Private Companies By Industry

Company Name Region
The Ouriel Group, LLC United States
Active Life Technologies LLC United States
GnuBIO, Inc. United States
Adaptive Biotechnologies Corporation United States
BioTeam Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ChemDiv, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at